AAAAAA

   
Results: 1-25 | 26-28 |
Results: 26-28/28
Influence of aromatase inhibitors on plasma total homocysteine in postmenopausal breast cancer patients
Authors: Anker, GB Refsum, H Ueland, PM Johannessen, DC Lien, EA Lonning, PE
Citation: Gb. Anker et al., Influence of aromatase inhibitors on plasma total homocysteine in postmenopausal breast cancer patients, CLIN CHEM, 45(2), 1999, pp. 252-256
CYP17 and breast cancer risk: The polymorphism in the 5 ' flanking area ofthe gene does not influence binding to Sp-1
Authors: Kristensen, VN Haraldsen, EK Anderson, KB Lonning, PE Erikstein, B Karesen, R Gabrielsen, OS Borresen-Dale, AL
Citation: Vn. Kristensen et al., CYP17 and breast cancer risk: The polymorphism in the 5 ' flanking area ofthe gene does not influence binding to Sp-1, CANCER RES, 59(12), 1999, pp. 2825-2828
Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinoma
Authors: Diamandis, EP Helle, SI Yu, H Melegos, DN Lundgren, S Lonning, PE
Citation: Ep. Diamandis et al., Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinoma, CANCER, 85(4), 1999, pp. 891-898
Risultati: 1-25 | 26-28 |